TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has shared an announcement.
EBR Systems, Inc. announced its participation in the Bell Potter Healthcare Conference 2025, where management will present their pioneering wireless cardiac pacing technology. This virtual event provides a platform for EBR Systems to showcase its WiSE technology, which could significantly impact the cardiac pacing industry by offering a more anatomically correct and less invasive solution for heart failure patients. The conference presentation is an opportunity for EBR Systems to strengthen its industry positioning and engage with stakeholders about its innovative approach to cardiac rhythm management.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Silicon Valley-based EBR Systems, Inc. is a company focused on advancing cardiac rhythm disease treatment through its innovative wireless cardiac pacing technology. Their proprietary Wireless Stimulation Endocardially (WiSE) technology aims to improve the effectiveness and reliability of cardiac resynchronization therapy by eliminating the need for traditional pacing leads, which are often associated with complications. The company’s initial product targets heart failure patients requiring Cardiac Resynchronization Therapy (CRT), with future products potentially addressing other cardiac and non-cardiac conditions.
Average Trading Volume: 636,371
Technical Sentiment Signal: Sell
Current Market Cap: A$503.9M
See more data about EBR stock on TipRanks’ Stock Analysis page.

